查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2009273

醫用解凍系統市場規模、佔有率、趨勢和預測：按產品類型、檢體類型、最終用戶和地區分類，2026-2034年

Medical Thawing System Market Size, Share, Trends and Forecast by Product Type, Sample Type, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球醫用解凍系統市場規模為2.33億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到4.017億美元，2026年至2034年的複合年成長率（CAGR）為6.05%。目前，北美市場佔據主導地位，預計到2025年將佔據超過47.3%的市場。北美地區的領先地位得益於其先進的醫療基礎設施、技術創新以及生物製藥解決方案的日益普及。

隨著醫療產業不斷向個人化醫療和創新治療方法轉型，對高效可靠的解凍系統的需求日益成長。例如，2024年8月，Cardinal Health在田納西州拉文市開設了一座佔地8,000平方英尺的先進治療研發中心。該中心配備了低溫儲存設施，能夠提升細胞和基因療法的商業化和物流效率，直接解決解凍過程中精確控溫以維持檢體活性的難題。這些系統在生物檢體（包括幹細胞和組織移植）的保存和處理中發揮著至關重要的作用。這些檢體必須在精確控制的溫度下解凍，才能保持其活性和功能。此外，慢性病發病率的上升和外科手術數量的增加也推動了對這些技術的需求，使其應用變得至關重要。因此，醫療機構和生技公司正大力投資研發更先進的解凍技術。

美國透過向醫療機構和實驗室提供最先進的設備和技術，在醫療解凍系統市場中扮演著日益重要的角色。隨著對高效、精準解凍系統需求的成長，美國製造商不斷創新，以滿足醫療產業的需求。美國公司致力於提供具有精準控制和可靠性能的高品質解凍系統，以確保生物檢體和醫療產品的安全高效解凍。此外，美國公司處於全球醫療解凍系統市場的前沿，透過研發提供有助於改善患者照護和推動醫學研究進步的解決方案。例如，截至2024年8月，美國國家器官移植等待名單上有超過11.4萬人，其中每年近6,000人因未取得器官而死亡。因此，解凍系統等先進醫療技術迫在眉睫，因為高效的解凍技術直接影響移植器官的保存和存活率。

醫療解凍系統市場趨勢：

生物製藥和再生醫學領域的需求日益成長

生物製藥和再生醫學的廣泛應用推動了對高效醫用解凍解決方案的需求。這些產業需要精確的解凍方案來維持生物樣本（例如細胞療法、幹細胞和基因療法產品）的完整性和活性。慢性病以及病毒和細菌感染疾病患者數量的不斷增加是市場的主要促進因素。這與器官移植日益成長的趨勢相吻合，而輸血需求的增加也導致了器官捐贈者數量的上升。對再生醫學日益成長的需求促使人們渴望安全且有效率地解凍幹細胞、組織和其他生物樣本，推動了該市場的成長。預計2024年，全球再生醫學市場規模將達267億美元。

擴建血庫及冷凍保存設施

全球血庫和冷凍保存設施的擴張顯著推動了醫用解凍市場的成長。例如，2024年9月，聖地牙哥血庫與聖地牙哥海洋世界合作，從超過11,000名捐血者身上採集了17,000份血液製品，挽救了34,000人的生命，並加強了該地區的醫療基礎設施。對包括血漿和紅血球在內的冷凍血液製品的需求不斷成長，凸顯了解凍系統在緊急和常規醫療程序中的關鍵作用。此外，器官移植、生育治療和幹細胞庫等領​​域對冷凍保存技術的日益關注，也強調了對可靠解凍解決方案的需求。這些機構採用先進的解凍設備，可確保按照醫療產業標準快速安全地製備檢體，從而進一步促進市場擴張。

人口老化導致對除霜解決方案的需求不斷成長。

人口老化正成為影響醫療解凍市場的重要因素。聯合國預測，全球65歲及以上人口比例將從2022年的10%增加到2050年的16%，成長率超過其他年齡層。需要先進醫療手段治療的老齡化相關疾病，例如心血管疾病、糖尿病和癌症，其發生率正在上升。這些治療通常需要生物製藥、冷凍保存的血液製品和再生醫學，而所有這些都需要精準高效的解凍流程。此外，為老年患者提供先進治療和手術支援的需求，也推動了對冷凍血漿、幹細胞和器官保存解決方案的需求成長。具備精確溫度控制和快速處理能力的醫療解凍系統對於確保這些治療的安全性和有效性至關重要。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球醫療解凍系統市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品類型分類

  • 手動的
  • 自動的

第7章 市場區隔：依檢體類型

  • 血
    • 主要部分
      • 電漿
      • 幹細胞
      • 全血
      • 血小板
  • 胚胎
  • 卵子
  • 精液

第8章 市場區隔：依最終用戶分類

  • 血庫
  • 醫院
  • 組織函式庫
  • 製藥和生物技術公司
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Barkey GmbH & Co. KG
    • BioLife Solutions, Inc.
    • Boekel Scientific
    • Cardinal Health
    • FreMon Scientific, Inc.
    • Helmer Scientific Inc.
    • KW Apparecchi Scientifici srl
    • Labcold
    • QED Scientific Ltd
    • Sarstedt AG & Co. KG
    • Thermo Fisher Scientific Inc.
Product Code: SR112026A4790

The global medical thawing system market size was valued at USD 233.0 Million in 2025. Looking forward, IMARC Group estimates the market to reach USD 401.7 Million by 2034, exhibiting a CAGR of 6.05% during 2026-2034. North America currently dominates the market, holding a significant market share of over 47.3% in 2025. This region's dominance is driven by advanced healthcare infrastructure, technological innovations, and increasing adoption of biopharmaceutical solutions.

As the healthcare industry continues to move toward personalized medicine and innovative treatment modalities, there is a need for effective and reliable thawing systems. For instance, in August 2024, Cardinal Health recently launched an 8,000 sq. ft. Advanced Therapy Innovation Center in La Vergne, Tennessee, which features cryogenic storage and enhanced capabilities for cell and gene therapy commercialization and logistics, directly addressing the need for precise temperature control during thawing to maintain sample viability. These systems hold a critical position for keeping and processing biological samples including stem cells and tissue grafts, which have to be thawed at an accurately maintained temperature to preserve the samples' viability and functionalities. Moreover, the escalating trend of chronic diseases along with the increased rate of surgeries call for such technologies making these inevitable; therefore, massive investments are made by healthcare facilities and biopharmaceutical companies towards even more advanced thawing technologies.

The United States is increasingly playing a significant role in the medical thawing system market by providing state-of-the-art equipment and technology to healthcare facilities and laboratories. With growing demands for efficient and accurate thawing systems, US manufacturers are continuously innovating for the needs of the medical industry. US companies are dedicated to the provision of high-quality thawing systems with precise control and reliable performance for the safe and efficient thawing of biological samples and medical products. Furthermore, US businesses are at the forefront in the global medical thawing system market, providing solutions that enhance patient care and advance medical research through research and development. For example, as of August 2024, more than 114,000 people are on the U.S. national transplant waiting list, and nearly 6,000 of them die every year without receiving an organ, so there is a dire need for advanced medical technologies such as thawing systems since efficient thawing technologies can have a direct impact on the preservation and viability of transplant organs.

MEDICAL THAWING SYSTEM MARKET TRENDS:

Rising Demand in Biopharmaceutical and Regenerative Medicine Applications

The growing use of biopharmaceuticals and regenerative medicine is driving the demand for effective medical thawing solutions. These industries need to follow accurate thawing protocols in order to maintain the integrity and viability of biological samples such as cell therapies, stem cells, and gene therapy products. The growing number of patients with chronic diseases and viral and bacterial infections is one of the main drivers for the market. This is in line with the fact that the propensity to opt for organ transplants is increasing, the number of organ donors are also on the rise with a rising demand for transfusion of blood. The raising need for regenerative medicines has been fueling the desire to thaw stem cells, tissue and other biological samples safety and efficiently, which therefore leads to the growth in this market. The global regenerative medicine market size reached USD 26.7 Billion in 2024.

Expansion of Blood Banks and Cryopreservation Facilities

The global expansion of blood banks and cryopreservation facilities is significantly contributing to the growth of the medical thawing market. For instance, in September 2024, the San Diego Blood Bank and SeaWorld San Diego partnership resulted in 17,000 blood product donations from over 11,000 donors, saving 34,000 lives and boosting local health infrastructure. The rising demand for frozen blood products, including plasma and red blood cells, highlights the critical role of thawing systems in emergency and routine medical procedures. Furthermore, the growing focus on cryopreservation for organ transplants, fertility treatments, and stem cell banking underscores the need for reliable thawing solutions. The deployment of advanced thawing equipment in these facilities ensures the rapid and safe preparation of samples, aligning with healthcare industry standards and fueling market expansion.

Growing Need for Thawing Solutions Driven by an Aging Population

The aging population is emerging as a significant factor influencing the medical thawing market. The UN projects that the global population aged 65 and above will rise from 10% in 2022 to 16% by 2050, growing faster than those below that age. There is an increasing prevalence of age-related conditions, such as cardiovascular diseases, diabetes, and cancer, which require advanced medical treatments. These treatments often rely on biopharmaceuticals, cryopreserved blood products, and regenerative therapies, all of which necessitate precise and efficient thawing processes. Moreover, the demand for frozen plasma, stem cells, and organ preservation solutions is growing, driven by the need to support advanced therapies and surgical procedures for older patients. Medical thawing systems equipped with precise temperature controls and rapid processing capabilities are crucial for ensuring the integrity and efficacy of these treatments.

MEDICAL THAWING SYSTEM INDUSTRY SEGMENTATION:

Analysis by Product Type:

  • Manual
  • Automated

Manual stand as the largest component in 2025, holding around 56.5% of the medical thawing system market share. This dominance reflects the continued reliance on manual thawing systems due to their simplicity, cost-effectiveness, and widespread use in various healthcare and laboratory settings. Manual systems are particularly favored in smaller facilities and resource-constrained environments where advanced automated solutions may not be feasible. Their ability to provide precise control during thawing processes, combined with ease of operation and maintenance, makes them a practical choice for many applications. As the demand for blood products, cryopreserved samples, and biological therapies continues to grow, the manual component remains an integral part of the global thawing market landscape.

Analysis by Sample Type:

  • Blood
    • Plasma
    • Stem Cells
    • Whole Blood
    • Platelets
  • Embryo
  • Ovum
  • Semen

Blood leads the market with around 53.2% of market share in 2025. This dominance underlines how important blood products are in modern-day healthcare, where efficient thawing systems are necessary for preparing plasma, red cells, and other components of blood for emergency and routine medical use. The growing occurrence of chronic diseases, greater surgical procedures, and the necessity of transfusions in cases of trauma and critical care are major drivers of this requirement. Advances in blood storage and preservation also increase the need for effective thawing technologies in ensuring that these products are safe and effective. In turn, this growing dependency further cements the segment's role in facilitating life-saving medical therapies.

Analysis by End User:

  • Blood Banks
  • Hospitals
  • Tissue Banks
  • Pharmaceutical and Biotech Companies
  • Others

Blood Banks leads the market with around 31.7% of market share in 2025. This leadership reflects the critical role blood banks play in the healthcare ecosystem, where efficient thawing systems are essential for preparing blood products such as plasma and red blood cells for emergency and routine medical procedures. The growing prevalence of chronic conditions and the increasing frequency of surgeries and trauma cases have amplified the demand for thawed blood products. Additionally, advancements in blood preservation techniques and the expansion of blood bank networks globally have driven the adoption of advanced thawing systems. These systems ensure rapid, precise, and safe thawing, aligning with healthcare standards and supporting the seamless delivery of life-saving treatments.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2025, North America accounted for the largest market share of over 47.3%. This dominance is attributed to the region's advanced healthcare infrastructure, widespread adoption of innovative medical technologies, and significant investment in biopharmaceutical research. The growing prevalence of chronic diseases, coupled with the rising demand for cell and gene therapies, has further fueled the need for efficient medical thawing systems. Additionally, the expansion of blood banks, cryopreservation facilities, and regenerative medicine practices has amplified the demand for precise and reliable thawing equipment. North America's focus on stringent healthcare standards and regulatory compliance continues to drive innovation and market growth, solidifying its position as a global leader in this sector.

KEY REGIONAL TAKEAWAYS:

UNITED STATES MEDICAL THAWING SYSTEM MARKET ANALYSIS

US accounts for 84.4% share of the market share in North America in 2025. The medical thawing market in the United States is primarily driven by the growing demand for advanced medical treatments, such as stem cell therapies, organ transplantation, and fertility treatments, all of which require precise thawing of biological samples. According to the Organ Procurement and Transplantation Network (OPTN), a total of 46,632 organ transplants were performed in 2023, from both living and deceased donors, highlighting the increasing need for effective organ preservation and thawing technologies. Additionally, the rapid growth in biotechnology and healthcare sectors, supported by innovations in cryopreservation techniques, is fueling the market. Technological advancements in thawing equipment, including automated systems that ensure uniform temperature control and reduce human error, are expected to drive adoption in hospitals and laboratories. The US government's support for medical research through grants and funding further boosts market growth. Moreover, the aging population in the US, which requires more organ transplants, contributes to the demand for effective thawing solutions. As healthcare providers seek to maintain the integrity of biological samples during thawing, the need for state-of-the-art systems to meet safety standards is growing, driving the expansion of the medical thawing market.

ASIA PACIFIC MEDICAL THAWING SYSTEM MARKET ANALYSIS

The medical thawing market in the Asia Pacific (APAC) region is experiencing growth driven by increasing healthcare investments and the rising prevalence of non-communicable diseases (NCDs). According to the World Health Organization, 55% of all deaths in South-East Asia are due to NCDs, equating to nearly 8 Million deaths annually. This escalating health burden is fueling the demand for advanced medical treatments, including organ transplants and stem cell therapies, which require effective thawing technologies. Additionally, the growing biotechnology and pharmaceutical industries, along with rising healthcare spending in countries like China, India, and Japan, further drive the adoption of thawing systems. The expanding number of fertility clinics and stem cell research centers is also contributing to market growth. As healthcare policies and infrastructure continue to improve, the demand for efficient, high-precision thawing solutions is expected to rise across the region.

EUROPE MEDICAL THAWING SYSTEM MARKET ANALYSIS

The medical thawing market in Europe is driven by the increasing demand for advanced medical treatments, particularly in fertility clinics, organ transplants, and regenerative medicine. With an aging population across European countries, the demand for organ transplants is on the rise, leading to a greater need for efficient thawing solutions to maintain the integrity of tissues and organs. According to Eurostat, as of January 1, 2023, the EU population was estimated at 448.8 Million, with over one-fifth (21.3%) aged 65 years and older, further contributing to the rising demand for organ transplants. Additionally, the growing number of stem cell research and cryopreservation services across Europe is fueling market growth. The regulatory frameworks set by authorities such as the European Medicines Agency (EMA) play a significant role in ensuring safe and standardized thawing practices, encouraging the use of advanced thawing equipment in medical facilities. Furthermore, significant investment in healthcare research, alongside the presence of well-established healthcare providers, supports the adoption of high-precision thawing systems. As the healthcare sector continues to evolve, the demand for medical thawing solutions in Europe is set to expand, driven by advancements in medical technologies and the increasing need for biologically preserved tissues.

LATIN AMERICA MEDICAL THAWING SYSTEM MARKET ANALYSIS

In Latin America, the medical thawing market is driven by increasing investments in healthcare infrastructure and advancements in biotechnology and medical research. According to PubMed Central, in Brazil alone, approximately 928,000 deaths annually are attributed to chronic diseases, creating a growing demand for treatments such as organ transplants and stem cell therapies, which require reliable thawing systems. The expanding number of fertility clinics and research centers further supports market growth. Additionally, rising healthcare expenditures and government initiatives to improve healthcare access are contributing to the market's expansion, fostering greater demand for medical thawing solutions in the region.

MIDDLE EAST AND AFRICA MEDICAL THAWING SYSTEM MARKET ANALYSIS

In the Middle East, the medical thawing market is driven by the increasing prevalence of chronic diseases and a growing demand for advanced treatments such as organ transplants and fertility therapies. In the UAE, as part of its multi-year fiscal plan for 2022-2026, the government has allocated USD 1.56 Billion (AED 5.74 Billion) for healthcare and community prevention services, reflecting a 10.4% increase from the 2024 budget. This investment is expected to boost healthcare infrastructure and adoption of advanced medical thawing technologies. The region's growing focus on biotechnology and stem cell research further supports the market's expansion.

COMPETITIVE LANDSCAPE:

The market is characterized by intense competition among players striving to gain a larger medical thawing system market share. Major participants in the market are concentrating on product innovation, strategic partnerships, mergers and acquisitions, as well as expanding geographically to enhance their presence in the market. Market participants are also making considerable investments in research and development efforts to improve their product ranges and maintain a competitive edge. The competitive environment of the medical thawing system market is anticipated to become more intense as new companies enter with groundbreaking technologies. For instance, in March 2024, Biolife Solutions patented a method for consistent thawing of frozen samples in bag-format vessels, utilizing temperature measurement, qualified sensors, and multiple heater banks for accurate, efficient thawing.

The report provides a comprehensive analysis of the competitive landscape in the medical thawing system market with detailed profiles of all major companies, including:

  • Barkey GmbH & Co. KG
  • BioLife Solutions, Inc.
  • Boekel Scientific
  • Cardinal Health
  • FreMon Scientific, Inc.
  • Helmer Scientific Inc.
  • KW Apparecchi Scientifici srl
  • Labcold
  • QED Scientific Ltd
  • Sarstedt AG & Co. KG
  • Thermo Fisher Scientific Inc.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the medical thawing system market?

2. What is the future outlook of the medical thawing system market?

3. What are the key factors driving the medical thawing system market?

4. Which region accounts for the largest medical thawing system market share?

5. Which are the leading companies in the global medical thawing system market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Medical Thawing System Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Manual
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Automated
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Sample Type

  • 7.1 Blood
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Plasma
      • 7.1.2.2 Stem Cells
      • 7.1.2.3 Whole Blood
      • 7.1.2.4 Platelets
    • 7.1.3 Market Forecast
  • 7.2 Embryo
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Ovum
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Semen
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Blood Banks
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospitals
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Tissue Banks
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Pharmaceutical and Biotech Companies
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Barkey GmbH & Co. KG
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 BioLife Solutions, Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Boekel Scientific
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Cardinal Health
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 FreMon Scientific, Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Helmer Scientific Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 KW Apparecchi Scientifici srl
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Labcold
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 QED Scientific Ltd
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Sarstedt AG & Co. KG
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Medical Thawing System Market: Major Drivers and Challenges
  • Figure 2: Global: Medical Thawing System Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Medical Thawing System Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 4: Global: Medical Thawing System Market: Breakup by Product Type (in %), 2025
  • Figure 5: Global: Medical Thawing System Market: Breakup by Sample Type (in %), 2025
  • Figure 6: Global: Medical Thawing System Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Medical Thawing System Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Medical Thawing System (Manual) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Medical Thawing System (Manual) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Medical Thawing System (Automated) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Medical Thawing System (Automated) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Medical Thawing System (Blood) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Medical Thawing System (Blood) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Medical Thawing System (Embryo) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Medical Thawing System (Embryo) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Medical Thawing System (Ovum) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Medical Thawing System (Ovum) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Medical Thawing System (Semen) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Medical Thawing System (Semen) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Medical Thawing System (Blood Banks) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Medical Thawing System (Blood Banks) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Medical Thawing System (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Medical Thawing System (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Medical Thawing System (Tissue Banks) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Medical Thawing System (Tissue Banks) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Medical Thawing System (Pharmaceutical and Biotech Companies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Medical Thawing System (Pharmaceutical and Biotech Companies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Medical Thawing System (Other End User) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Medical Thawing System (Other End User) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: North America: Medical Thawing System Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: North America: Medical Thawing System Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: United States: Medical Thawing System Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: United States: Medical Thawing System Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Canada: Medical Thawing System Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Canada: Medical Thawing System Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Asia-Pacific: Medical Thawing System Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Asia-Pacific: Medical Thawing System Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: China: Medical Thawing System Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: China: Medical Thawing System Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Japan: Medical Thawing System Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Japan: Medical Thawing System Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: India: Medical Thawing System Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: India: Medical Thawing System Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: South Korea: Medical Thawing System Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: South Korea: Medical Thawing System Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Australia: Medical Thawing System Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Australia: Medical Thawing System Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Indonesia: Medical Thawing System Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Indonesia: Medical Thawing System Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Others: Medical Thawing System Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Others: Medical Thawing System Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Europe: Medical Thawing System Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Europe: Medical Thawing System Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Germany: Medical Thawing System Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Germany: Medical Thawing System Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: France: Medical Thawing System Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: France: Medical Thawing System Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: United Kingdom: Medical Thawing System Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: United Kingdom: Medical Thawing System Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Italy: Medical Thawing System Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Italy: Medical Thawing System Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Spain: Medical Thawing System Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Spain: Medical Thawing System Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Russia: Medical Thawing System Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Russia: Medical Thawing System Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Others: Medical Thawing System Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Others: Medical Thawing System Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Latin America: Medical Thawing System Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Latin America: Medical Thawing System Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Brazil: Medical Thawing System Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Brazil: Medical Thawing System Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Mexico: Medical Thawing System Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Mexico: Medical Thawing System Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Others: Medical Thawing System Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Others: Medical Thawing System Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Middle East and Africa: Medical Thawing System Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Middle East and Africa: Medical Thawing System Market: Breakup by Country (in %), 2025
  • Figure 78: Middle East and Africa: Medical Thawing System Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Global: Medical Thawing System Industry: SWOT Analysis
  • Figure 80: Global: Medical Thawing System Industry: Value Chain Analysis
  • Figure 81: Global: Medical Thawing System Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Medical Thawing System Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Medical Thawing System Market Forecast: Breakup by Product Type (in Million USD), 2026-2034
  • Table 3: Global: Medical Thawing System Market Forecast: Breakup by Sample Type (in Million USD), 2026-2034
  • Table 4: Global: Medical Thawing System Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Medical Thawing System Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Medical Thawing System Market: Competitive Structure
  • Table 7: Global: Medical Thawing System Market: Key Players